Search Results - "Shah, N Sarita"

Refine Results
  1. 1
  2. 2

    Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings by Reid, Michael JA, MRCP, Shah, N Sarita, MD

    Published in The Lancet infectious diseases (01-03-2009)
    “…Summary Tuberculosis is the main cause of morbidity and mortality in people living with HIV/AIDS worldwide. Early diagnosis and treatment is essential to…”
    Get full text
    Journal Article
  3. 3

    Yield of Contact Investigations in Households of Patients With Drug-Resistant Tuberculosis: Systematic Review and Meta-Analysis by Shah, N. Sarita, Yuen, Courtney M., Heo, Moonseong, Tolman, Arielle W., Becerra, Mercedes C.

    Published in Clinical infectious diseases (01-02-2014)
    “…Contact investigations among individuals living with drug-susceptible tuberculosis patients (source cases) have shown a high yield of tuberculosis disease and…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis by Orenstein, Evan W, BS, Basu, Sanjay, PhD, Shah, N Sarita, MD, Andrews, Jason R, MD, Friedland, Gerald H, MD, Moll, Anthony P, MBChB, Gandhi, Neel R, MD, Galvani, Alison P, PhD

    Published in The Lancet infectious diseases (01-03-2009)
    “…Summary Multidrug-resistant (MDR) tuberculosis is a growing clinical and public-health concern. To evaluate existing evidence regarding treatment regimens for…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities by Auld, Sara C, Shah, N Sarita, Mathema, Barun, Brown, Tyler S, Ismail, Nazir, Omar, Shaheed Vally, Brust, James C M, Nelson, Kristin N, Allana, Salim, Campbell, Angela, Mlisana, Koleka, Moodley, Pravi, Gandhi, Neel R

    Published in The European respiratory journal (01-10-2018)
    “…Despite evidence that transmission is driving an extensively drug-resistant TB (XDR-TB) epidemic, our understanding of where and between whom transmission…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Extensively Drug-Resistant Tuberculosis in the United States, 1993-2007 by Shah, N. Sarita, Pratt, Robert, Armstrong, Lori, Robison, Valerie, Castro, Kenneth G, Cegielski, J. Peter

    “…CONTEXT Worldwide emergence of extensively drug-resistant tuberculosis (XDR-TB) has raised global public health concern, given the limited therapy options and…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Implications for the HIV Epidemic and Antiretroviral Therapy Rollout in South Africa by Andrews, Jason R, Sarita Shah, N, Gandhi, Neel, Moll, Tony, Friedland, Gerald

    Published in The Journal of infectious diseases (01-12-2007)
    “…Drug-resistant tuberculosis (TB) is emerging as a major clinical and public health challenge in areas of sub-Saharan Africa where there is a high prevalence of…”
    Get full text
    Journal Article Conference Proceeding
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Exogenous Reinfection as a Cause of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Rural South Africa by Andrews, Jason R., Gandhi, Neel R., Moodley, Prashini, Shah, N. Sarita, Bohlken, Louise, Moll, Anthony P., Pillay, Manormoney, Friedland, Gerald, Sturm, A. Willem

    Published in The Journal of infectious diseases (01-12-2008)
    “…Background. Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) are now major threats in areas of South Africa with a high…”
    Get full text
    Journal Article
  20. 20

    pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia by Allana, Salim, Shashkina, Elena, Mathema, Barun, Bablishvili, Nino, Tukvadze, Nestani, Shah, N Sarita, Kempker, Russell R, Blumberg, Henry M, Moodley, Pravi, Mlisana, Koleka, Brust, James C M, Gandhi, Neel R

    Published in Emerging infectious diseases (01-03-2017)
    “…Although pyrazinamide is commonly used for tuberculosis treatment, drug-susceptibility testing is not routinely available. We found polymorphisms in the pncA…”
    Get full text
    Journal Article